16 MAY 2013 NEW ZEALAND GAZETTE, No. 57 1689

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Botox®
Active Ingredient: Botulinum A toxin 100U
Dosage Form: Powder for injection
New Zealand Sponsor: Allergan New Zealand Limited
Manufacturer: Allergan Pharmaceuticals Ireland, County Mayo, Ireland

Product: Botox®
Active Ingredient: Botulinum A toxin 200U
Dosage Form: Powder for injection
New Zealand Sponsor: Allergan New Zealand Limited
Manufacturer: Allergan Pharmaceuticals Ireland, County Mayo, Ireland

Dated this 9th day of May 2013.

DR MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go2814

Classification of Medicines

Pursuant to section 106(1) of the Medicines Act 1981, I, Dr Mark Jacobs, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health, acting under delegated authority, hereby declare that the medicines listed in Schedule 1 to this notice are classified as prescription medicines.

Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources.

Unless specific reference is made otherwise, every reference applies also to medicines that:

(a) preparations and admixtures containing any proportion of any substance listed in the notice.

(b) salts and esters of any substance listed in the notice.

(c) preparations or extracts of biological materials listed in the notice.

(d) salts or oxides of elements listed in the notice.

Unless specific reference is made otherwise, every reference to a medicine applies:

(i) if the medicine is in an injection or eye preparation, to any concentration of that medicine; and

(ii) if the medicine is not in an injection or eye preparation, only if the concentration of the medicine is greater than 10 milligrams per litre or per kilogram.

Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using the free acid, base, alcohol or element unless specifically stated otherwise.

Schedule 1
Prescription Medicines
Canagliflozin
Pertuzumab
Teriflunomide
Trastuzumab emtansine

Dated this 8th day of May 2013.

DR MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health.

go2865

Dated at Wellington this 16th day of May 2013.

JEFF MONTGOMERY, Registrar-General.

Marriage Act 1955

go2876

Marriage (Approval of Organisations) Notice No. 12

Pursuant to the Marriage Act 1955, the Registrar-General of Marriages hereby gives notice as follows.

Notice

1. This notice may be cited as the Marriage (Approval of Organisations) Notice No. 12.

2. The organisations specified in the Schedule hereto are hereby declared to be approved organisations for the purpose of the Marriage Act 1955.

Schedule
Pooja Cultural Centre Trust.
Quota International Inc.

Marriage Celebrants for 2013 Notice No. 38

Pursuant to the provisions of section 11 of the Marriage Act 1955, the following name of a marriage celebrant within the meaning of the said Act is published for general information:

Cox, Mary, 74A Takutai Avenue, Half Moon Bay, Bucklands Beach, Auckland.

Dated at Wellington this 16th day of May 2013.

JEFF MONTGOMERY, Registrar-General.

go2877